Zymeworks appoints Kristin Stafford as CFO

Zymeworks (ZYME) announced the appointment of Kristin Stafford as CFO, effective April 1. Stafford recently served as Senior Vice President, Chief Accounting Officer for Royalty Pharma plc, since December 2018. Prior to this position, she served as Vice President, Finance of Royalty Pharma and CFO of BioPharma Credit,an affiliate of Royal Pharma, from 2016 to 2018. Previously, Stafford was a director at Ernst & Young Capital Markets in London, specializing in U.S. transactions involving European life sciences companies. She also previously managed the external SEC reporting for iHeartMedia and was an auditor at Deloitte. Stafford is currently a Board Member at Novocure (NVCR). She is a CPA and holds a B.Sc. degree in business administration from Sonoma State University.